Description of Research Expertise
Principal Site Investigator EUCLID Study (Examining Use of tiCagreLor In paD).
EUCLID is a randomized, double-blind, parallel group, multi-center study evaluating the
efficacy of ticagrelor (monotherapy) compared to clopidogrel (monotherapy) in reducing
the primary endpoint - a composite of CV death, MI or ischemic stroke - in patients with
PAD.
2012-2015
Academic Contact Information
Division of Vascular Surgery
Pennsylvania Hospital
Suite 101, 700 Spruce Street
Philadelphia,
PA
19104
Phone: 215-829-5000
Patient appointments: 800-789-7366